newsfilter
← Latest News
GlobeNewswire·

Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential

JUPITER, Fla., July 07, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ:DYAI) ("Dyadic" or the "Company"), d/b/a Dyadic Applied BioSolutions, a biotechnology company focused on the